Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Erlotinib has moderate single-agent activity in chemotherapy-naïve castration-resistant prostate cancer: final results of a phase II trial.
Urology. 2009 Sep;74(3):665-71. doi: 10.1016/j.urology.2009.05.016. Epub 2009 Jul 17.
Urology. 2009.
PMID: 19616281
Clinical Trial.
Lenalidomide monotherapy in chemotherapy-naive, castration-resistant prostate cancer patients: final results of a phase II study.
Nabhan C, Patel A, Villines D, Tolzien K, Kelby SK, Lestingi TM.
Nabhan C, et al. Among authors: kelby sk.
Clin Genitourin Cancer. 2014 Feb;12(1):27-32. doi: 10.1016/j.clgc.2013.09.001. Epub 2013 Oct 1.
Clin Genitourin Cancer. 2014.
PMID: 24238760
Clinical Trial.
Item in Clipboard
Cite
Cite